Patient-Reported Outcome Labeling for Cardiovascular Drugs Approved in the United States: 2011-2017

被引：0
|
作者：
Zettler, Marjorie E. [1 ]
Lieu, Hsiao [2 ]
机构：
[1] Cardinal Hlth Specialty Solut, Regulatory Sci, Overland Pk, KS USA
[2] Genentech Inc, OMNI, GRED Early Clin Dev, San Francisco, CA 94080 USA
来源：
CIRCULATION | 2018年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10649
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A Review of Patient-Reported Outcome Labeling of FDA-Approved New Drugs (2016-2020): Counts, Categories, and Comprehensibility
    Gnanasakthy, Ari
    Norcross, Lindsey
    Romano, Carla
    Carson, Robyn T.
    VALUE IN HEALTH, 2022, 25 (04) : 647 - 655
  • [22] Analysis of patient-reported outcomes in the approval of novel oncology drugs in the United States, 2017-2022
    Ge, Chenghao
    Guo, Kaiyuan
    Li, Yi
    Li, Guanqiao
    Zhang, Hong
    Yang, Jiaxuan
    Liu, Yang
    Yin, Chen
    Liu, Sen
    Xie, Songmei
    Chen, Xiaoyuan
    ECLINICALMEDICINE, 2023, 59
  • [23] RATES OF PATIENT-REPORTED OUTCOME CLAIMS FOR ORPHAN DRUGS APPROVED BY THE EUROPEAN MEDICINES AGENCY
    Jaroslawski, S.
    Toumi, M.
    Auquier, P.
    Dussart, C.
    VALUE IN HEALTH, 2018, 21 : S109 - S109
  • [24] PATIENT-REPORTED OUTCOME (PRO) CLAIMS IN PRODUCTS APPROVED FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) IN EUROPE AND THE UNITED STATES
    Caron, M.
    Perrier, L. L.
    Acquadro, C.
    VALUE IN HEALTH, 2013, 16 (07) : A374 - A375
  • [25] The changing landscape of naloxone availability in the United States, 2011-2017
    Freeman, Patricia R.
    Hankosky, Emily R.
    Lofwall, Michelle R.
    Talbert, Jeffery C.
    DRUG AND ALCOHOL DEPENDENCE, 2018, 191 : 361 - 364
  • [26] A REVIEW OF PATIENT-REPORTED OUTCOMES LABELING FOR ONCOLOGY PRODUCTS APPROVED BY FDA AND EMA FROM 2017 TO 2018
    Shao, Q.
    Liang, Y.
    Liu, Y. S.
    Rascati, K.
    VALUE IN HEALTH, 2020, 23 : S76 - S76
  • [27] A Review of Patient-Reported Outcome Labels in the United States: 2006 to 2010
    Gnanasakthy, Ari
    Mordin, Margaret
    Clark, Marci
    DeMuro, Carla
    Fehnel, Sheri
    Copley-Merriman, Catherine
    VALUE IN HEALTH, 2012, 15 (03) : 437 - 442
  • [28] Prevalence and Incidence of Obesity and Diabetes in the United States, 2011-2017
    Nielsen, Jannie
    Gregg, Ed
    Narayan, K. M. Venkat
    Cunningham, Solveig A.
    DIABETES, 2020, 69
  • [29] A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016)
    Gnanasakthy, Ari
    Barrett, Amy
    Evans, Emily
    D'Alessio, Denise
    Romano, Carla
    VALUE IN HEALTH, 2019, 22 (02) : 203 - 209
  • [30] FDA labeling based on patient-reported outcome diaries
    Gnanasakthy, Ari
    Carty, Michelle
    QUALITY OF LIFE RESEARCH, 2024, 33 : S16 - S16
12345